Tibotec Pharmaceuticals Ltd. announced that it has submitted an application for marketing authorisation for TMC125 to the European Agency for the Evaluation of Medicinal Products (EMEA).
The U.S. Food and Drug Administration announced that it is permitting the restricted use of Zelnorm (tegaserod maleate) under a treatment investigational new drug (IND) protocol to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC) in women younger than 55 who meet specific guidelines.
More cases of venous thromboembolism are diagnosed in the three months following hospitalization than during hospitalization, but less than half of inpatients receive medications to prevent blood clots from occurring, according to a report in the July 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
A study of Medicare patients with osteoarthritis provides additional evidence that non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin reduce the risk of colorectal cancer.
Results from a new study involving high blood pressure patients taking Tekturna? (aliskiren) and Diovan? (valsartan) were published in The Lancet.
Growth hormone injections appear to boost height in extremely short, healthy children, according to a recent systematic review, but height gain appears to peak at about three inches ? and those inches are expensive.
The commonly used and inexpensive analgesic acetaminophen (Tylenol or paracetamol) is an effective pain reliever after surgical removal of lower wisdom teeth, according to a new systematic review of 21 studies. The most effective dose appears to be 1,000 milligrams taken at six-hour intervals, the review concludes.
Researchers at the University of Minnesota have found that a drug originally developed to fight tuberculosis may help people with obsessive-compulsive disorder make more progress in therapy sessions.
Men and their physicians need not hesitate to use a drug proven effective in preventing prostate cancer out of concern that it is likely to cause sexual dysfunction, say authors of a study conducted by the Southwest Oncology Group.
Little evidence supports using rosiglitazone (Avandia) to improve the quality or length of life among adults with diabetes, according to a systematic review of data by German researchers.